Why is Fortis Health. falling/rising?

As of 10-Nov, Fortis Healthcare Ltd's stock price is currently at 992.10, reflecting a decline of 28.25 points or 2.77%. The stock has underperformed its sector today by 1.19%, reaching an intraday low of Rs 983.4, which is a decrease of 3.62%. Over the past week, the stock has decreased by 3.71%, and in the last month, it has fallen by 6.76%. Despite these short-term declines, the stock has shown impressive long-term performance, with a year-to-date increase of 37.87% and a remarkable 59.78% rise over the past year. The company maintains a strong ability to service debt, evidenced by a low Debt to EBITDA ratio of 1.15 times, and has demonstrated healthy long-term growth with an annual operating profit growth rate of 79.69%. Additionally, high institutional holdings at 57.05% suggest that knowledgeable investors are backing the stock, which may provide some stability despite recent price drops.
In the broader market context, Fortis Healthcare's recent performance contrasts with the Sensex, which has only decreased by 0.53% over the past week. This indicates that the stock's short-term struggles are more pronounced than the overall market trend. While the stock has shown consistent returns over the last three years, outperforming the BSE500, the recent decline may reflect short-term market pressures or investor sentiment rather than fundamental weaknesses. The rising investor participation, with an increase in delivery volume, suggests that there is still interest in the stock, which could lead to a potential rebound if market conditions improve.